Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Cyxone chooses to complete acquisition of rabeximod

June 5, 2018

EMA CHMP recommends approval of Sandoz adalimumab biosimilar

June 4, 2018

FDA approves Olumiant 2 mg for moderate to severe rheumatoid arthritis

June 4, 2018

Astellas submits application for marketing approval of peficitinib in Japan

June 1, 2018

Phase II EQUATOR study of filgotinib in psoriatic arthritis meets primary endpoint

May 31, 2018

ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE

May 29, 2018

Croma-Pharma identifies H2S-releasing compounds

May 28, 2018

Lupin submits MAA to the EMA for etanercept biosimilar

May 28, 2018

First patient enrolled in SARA-INT study of Sarconeos in sarcopenia

May 28, 2018

Chugai seeks Japanese approval for Actemra for adult-onset Still's disease

May 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...